ClinVar Miner

Submissions for variant NM_000018.4(ACADVL):c.342+1G>A

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen ACADVL Variant Curation Expert Panel, ClinGen RCV002286684 SCV002576750 likely pathogenic Very long chain acyl-CoA dehydrogenase deficiency 2022-09-23 reviewed by expert panel curation The c.342+1G>A variant in ACADVL is a splice site variant affecting the canonical donor splice site in intron 5. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product. This variant is present at low frequency (<0.1%) in population databases (ExAC). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site (Splice AI). This variant has not been reported in the literature either in functional studies or in patients with VLCAD and there is no entry in ClinVar. This variant is classified as Likely Pathogenic based on ACADVL-specific ACMG/AMP criteria PVS1 and PM2.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.